Abstract
Twenty-eight thyrotoxic patients were treated with propranolol. In seven patients the drug had to be discontinued after one or two months, but in the remaining 21 clinical improvement was observed. Serial clinical studies and tests of thyroid function performed at monthly intervals showed that in four patients thyrotoxicosis remitted and all indices of thyroid function returned to normal. A fifth patient shows distinct evidence of remission with the 20-minute 132I uptake falling to normal, although the free-thyroxine index remains slightly raised. It is likely that these remissions reflect the natural tendency of the disease to remit since propranolol is not considered to have any direct in-vivo effect on thyroid function.
However, because of failure to gain adequate control of symptoms in all patients treated, and the fact that circulating thyroid hormone levels were often not restored to normal, propranolol is considered an unsatisfactory alternative to conventional antithyroid drugs for routine treatment.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alexander W. D., Harden R. M., Shimmins J. Studies of the thyroid iodide "trap" in man. Recent Prog Horm Res. 1969;25:423–446. doi: 10.1016/b978-0-12-571125-8.50012-0. [DOI] [PubMed] [Google Scholar]
- Alexander W. D., McLarty D. G., Horton P., Pharmakiotis A. D. Sequential assessment during drug treatment of thyrotoxicosis. Clin Endocrinol (Oxf) 1973 Jan;2(1):43–50. doi: 10.1111/j.1365-2265.1973.tb03483.x. [DOI] [PubMed] [Google Scholar]
- Becker F. O., Schwartz T. B. Sympathetic blockade in hyperthyroidism. Preoperative management following toxic reaction to antithyroid drugs. Arch Intern Med. 1972 Jun;129(6):967–971. doi: 10.1001/archinte.129.6.967. [DOI] [PubMed] [Google Scholar]
- Biran S., Tal E. Effect of beta-blocking drug propranolol on 131 I utilization in euthyroid patients. J Clin Pharmacol New Drugs. 1972 Feb-Mar;12(2):105–107. doi: 10.1002/j.1552-4604.1972.tb00154.x. [DOI] [PubMed] [Google Scholar]
- CROOKS J., WAYNE E. J., ROBB R. A. A clinical method of assessing the results of therapy in thyrotoxicosis. Lancet. 1960 Feb 20;1(7121):397–401. doi: 10.1016/s0140-6736(60)90334-2. [DOI] [PubMed] [Google Scholar]
- Das G., Krieger M. Treatment of thyrotoxic storm with intravenous administration of propranolol. Ann Intern Med. 1969 May;70(5):985–988. doi: 10.7326/0003-4819-70-5-985. [DOI] [PubMed] [Google Scholar]
- Hadden D. R., Bell T. K., McDevitt D. G., Shanks R. G., Montgomery D. A., Weaver J. A. Propranolol and the utilization of radioiodine by the human thyroid gland. Acta Endocrinol (Copenh) 1969 Jul;61(3):393–399. doi: 10.1530/acta.0.0610393. [DOI] [PubMed] [Google Scholar]
- Hershman J. M., Givens J. R., Cassidy C. E., Astwood E. B. Long-term outcome of hyperthyroidism treated with antithyroid drugs. J Clin Endocrinol Metab. 1966 Aug;26(8):803–807. doi: 10.1210/jcem-26-8-803. [DOI] [PubMed] [Google Scholar]
- Pimstone B., Joffe B., Pimstone N., Bonnici F., Jackson W. P. Clinical response to long-term propranolol therapy in hyperthyroidism. S Afr Med J. 1969 Sep 27;43(39):1203–1205. [PubMed] [Google Scholar]
- Vinik A. I., Pimstone B. L., Hoffenberg R. Sympathetic nervous system blocking in hyperthyroidism. J Clin Endocrinol Metab. 1968 May;28(5):725–727. doi: 10.1210/jcem-28-5-725. [DOI] [PubMed] [Google Scholar]